Secura Bio Media

News and Events

JUN 09, 2021, 9:00 AM ET

COPIKTRA® (duvelisib) Receives European Union Marketing Authorization for the Treatment of Relapsed or Refractory CLL and Refractory FL

View Press Release »

FEB 02, 2021, 9:00 AM ET

Secura Bio Announces New Data Regarding the Combination of FARYDAK® (panobinostat) with Subcutaneous Bortezomib and Dexamethasone

View Press Release »

AUG 10, 2020, 9:23 AM ET

Secura Bio Signs Agreement to Acquire Global Rights to Oncology Drug Copiktra®

View Press Release »

Mar 05, 2019, 10:07 AM ET

Secura Bio Announces $145 Million Financing Led By Athyrium Capital Management

View Press Release »